40,000 Shares in Danaher Corporation $DHR Bought by Archon Partners LLC

Archon Partners LLC purchased a new position in shares of Danaher Corporation (NYSE:DHR) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 40,000 shares of the conglomerate’s stock, valued at approximately $9,157,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. JPL Wealth Management LLC purchased a new stake in Danaher during the 3rd quarter worth $25,000. WFA of San Diego LLC purchased a new stake in Danaher during the 2nd quarter worth $26,000. Elevated Capital Advisors LLC purchased a new stake in Danaher during the 4th quarter worth $26,000. ANTIPODES PARTNERS Ltd purchased a new stake in Danaher during the 3rd quarter worth $27,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher during the fourth quarter worth approximately $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the subject of a number of recent analyst reports. Royal Bank Of Canada initiated coverage on shares of Danaher in a research report on Thursday, May 14th. They set an “outperform” rating and a $200.00 price target for the company. Citigroup initiated coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target for the company. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Rothschild & Co Redburn set a $205.00 price target on shares of Danaher in a research report on Friday, April 17th. Finally, TD Cowen lowered their price objective on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $233.61.

Danaher Trading Down 1.9%

NYSE:DHR opened at $177.85 on Thursday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The business’s 50 day moving average is $180.26 and its two-hundred day moving average is $203.59. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a market cap of $125.88 billion, a PE ratio of 34.40, a P/E/G ratio of 2.31 and a beta of 0.81.

Danaher (NYSE:DHR) last released its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter last year, the business posted $1.88 EPS. Danaher’s quarterly revenue was up 3.7% compared to the same quarter last year. On average, analysts predict that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.